HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cerutti, F. Articles by Sacchetti, C. Search for Related Content PubMed PubMed Citation Articles by Cerutti, F. Articles by Sacchetti, C. Social Bookmarking                What's this?

Younger Age at Onset and Sex Predict Celiac Disease in Children and Adolescents With Type 1 Diabetes

An Italian multicenter study

¹ Department of Pediatrics, University of Torino, Torino, Italy
² Department of Internal Medicine, University of Torino, Torino, Italy
³ Department of Pediatrics, University of Chieti, Chieti, Italy
⁴ Department of Pediatrics, University of Genova, G. Gaslini Institute, Genova, Italy
⁵ Department of Pediatrics, University of Milano, Vita-Salute H.S. Raffaele, Milano, Italy

Address correspondence and reprint requests to Dr. Franco Cerutti, Dipartimento di Scienze Pediatriche e dell’Adolescenza, Università di Torino, Piazza Polonia 94, I-10126, Torino, Italy. E-mail: franco.cerutti{at}unito.it

	ABSTRACT

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

 
OBJECTIVE—To estimate the prevalence of biopsy-confirmed celiac disease in Italian children and adolescents with type 1 diabetes and to assess whether age at onset of type 1 diabetes is independently associated with diagnosis of celiac disease.

RESEARCH DESIGN AND METHODS—The study group was a clinic-based cohort of children and adolescents with type 1 diabetes cared for in 25 Italian centers for childhood diabetes. Yearly screening for celiac disease was performed using IgA/IgG anti-gliadin and IgA anti-endomysium antibodies.

RESULTS—Of the 4,322 children and adolescents (age 11.8 ± 4.2 years) identified with type 1 diabetes, biopsy-confirmed celiac disease was diagnosed in 292 (prevalence 6.8%, 95% confidence interval [CI] 6.0–7.6), with a higher risk seen in girls than in boys (odds ratio [OR] 1.93, 1.51–2.47). In 89% of these, diabetes was diagnosed before celiac disease. In logistic regression analyses, being younger at onset of diabetes, being female, and having a diagnosis of a thyroid disorder were independently associated with the risk of having diabetes and celiac disease. In comparison with subjects who were older than 9 years at onset of diabetes, subjects who were younger than 4 years at onset had an OR of 3.27 (2.20–4.85).

CONCLUSIONS—We have provided evidence that 1) the prevalence of biopsy-confirmed celiac disease in children and adolescents with type 1 diabetes is high (6.8%); 2) the risk of having both diseases is threefold higher in children diagnosed with type 1 diabetes at age <4 years than in those age >9 years; and 3) girls have a higher risk of having both diseases than boys.

Abbreviations: EMA, anti-endomysium antibody

	INTRODUCTION

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

 
The association between celiac disease and other autoimmune diseases, particularly type 1 diabetes and thyroid-related autoimmune disorders, has been documented in several studies (1). In a comparison of 40 surveys conducted mainly in European countries (1), the median prevalence of celiac disease with regard to type 1 diabetes has been estimated at 4.1%. A possible explanation for this association could be that the same susceptibility genotypes are involved in the etiopathogenesis of diabetes and celiac disease. In both diseases, genetic susceptibility is associated with the HLA-DQ 1*0501, ß1*0201 heterodimer, which preferentially presents gluten-derived gliadin peptides on its antigen-presenting groove to stimulate intestinal mucosal T-cells (2). Moreover, impaired intestinal permeability in subjects with untreated celiac disease could increase the absorption of dietary antigens, which in turn could induce an autoimmune reaction in subjects with genetic susceptibility to autoimmune diseases (3).

Recently, some (4,5), but not all (6,7) studies have suggested an association between the age at diagnosis of celiac disease and autoimmune disorders with patients who were older at diagnosis of celiac disease and, presumably having had longer exposure to dietary gluten, being at higher risk for developing autoimmune disease. Studies have suggested a heterogeneity of determinants of type 1 diabetes by age at onset (8). To date, however, no study has had the statistical power to assess whether the diagnosis of celiac disease is associated with age at onset of type 1 diabetes, with most of the studies recruiting only small numbers of children with diabetes. Evidence for this association would be consistent with the hypothesis of common determinants for both diseases, at least in subgroups of patients.

The present large, multicenter survey was designed to estimate the prevalence of celiac disease in Italian children and adolescents with type 1 diabetes. To test whether there is heterogeneity by age at onset of type 1 diabetes, using multivariate analyses we also assessed whether age at onset of type 1 diabetes is independently associated with diagnosis of celiac disease.

	RESEARCH DESIGN AND METHODS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

 
The study base of this report was a clinic-based cohort of children and adolescents with type 1 diabetes on the prevalence date (31 December 2001) cared for in 25 Italian centers for childhood diabetes. In Italy, >95% of diabetic children and adolescents are followed in diabetes clinics through the national health system. As shown in Fig. 1, recruited centers were spread out all over Italy (11 in the north, 5 in the center, and 9 in the south) and represented 60% of Italian clinics for childhood diabetes.

View larger version (81K): [in this window] [in a new window]   Figure 1— Geographic distribution of the 25 Italian collaborative centers for childhood diabetes.

Data are shown as frequencies, means ± SD, and interquartile range of distribution. ANOVA and ² tests were applied whenever appropriate. To assess variables independently associated with the prevalence of celiac disease, we performed logistic regression analyses, with the prevalence of celiac disease as the dependent variable and age, sex, age at diagnosis of diabetes (quartiles defined by age <4 years, 4–6 years, 7–9 years, and >9 years), and presence or absence of a thyroid disorder as covariates. The –2 log likelihood ratio test was used to test the significance of variables. All analyses were performed using Stata (Stata Release 8.0; Stata, College Station, TX).

	RESULTS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

 
On the prevalence date (31 December 2001), 4,322 children and adolescents (2,388 boys and 1,934 girls) with type 1 diabetes were followed in 25 pediatric diabetes clinics spread out all over Italy (Fig. 1). The ages at recruitment and diabetes diagnosis were 11.8 ± 4.2 and 7.4 ± 3.9 years, respectively. Out of this cohort, biopsy-confirmed celiac disease was diagnosed in 292 subjects, giving a prevalence of 6.8% (95% confidence interval [CI] 6.0–7.6), with higher risk in girls than in boys (odds ratio [OR] 1.93, 95% CI 1.51–2.47).

As shown in Tables 1 and 2, the onset of type 1 diabetes preceded the diagnosis of celiac disease in most subjects (258 of 292, 88.4%), whereas the diagnosis of celiac disease preceded that of diabetes in 34 of 292 (11.6%). In 31 of the 258 subjects (12.0%), the diseases were diagnosed simultaneously as a result of screening. Out of 258 patients having diabetes onset before celiac disease diagnosis, 14.5% displayed symptoms of celiac disease, with 13% having gastrointestinal symptoms and 1.5% having atypical symptoms (short stature and/or anemia). Among them, the median lag between diagnoses was 1.3 years (interquartile range 0.25–3.58), whereas in those for whom diabetes was diagnosed after celiac disease, the median lag between diagnoses was 4.93 years (interquartile range 3.21–8.96 years). After excluding patients with celiac disease diagnosed at onset of diabetes, 75 and 95% of patients had celiac disease diagnosed by 4.2 years and 9.4 years of duration of diabetes, respectively. Table 3 shows the number of diabetic patients screened per year since 1995 and prevalence of biopsy-confirmed celiac disease by strata of duration of diabetes, after excluding subjects with celiac disease diagnosed before diabetes onset (n = 34) and those diagnosed before implementation of the yearly screening program (n = 55). A decreasing trend after the onset of diabetes was found; in subjects with diabetes duration >9 years, the upper CI limit was 1.2%, thus providing evidence that using a conservative approach, celiac disease is rarely found after 10 years’ duration of diabetes.

	CONCLUSIONS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

The possibility that gluten has a role in ß-cell autoimmunity has been suggested by reports showing that diabetes-related antibodies disappear in BB rats fed a gluten-free diet (13). In humans, a small prospective study of 11 children confirmed that observation; however, all patients had single autoantibody positivity and very low risk of progression to diabetes (4). In another study conducted in high-risk relatives of type 1 diabetic patients, elimination of dietary gluten did not modify either levels of autoantibodies or progression to diabetes (14). Recently, a clinic-based cohort of nondiabetic adults with celiac disease was shown to have a fourfold increased prevalence of type 1 diabetes–related autoantibodies in patients with >9 years’ duration of gluten withdrawal than in those with a duration <5 years (95% CI 1.51–10.6), even after adjusting for age, sex, presence of other autoimmune diseases, and compliance with diet (15). Altogether, these observations suggest that the association between celiac disease and type 1 diabetes is more complex. Dietary gluten could act as a modifier rather than a determinant of the etiopathogenesis of type 1 diabetes, facilitating the progression of other dietary factors to the lamina propria, where they activate the autoimmune response against ß-cells in subjects with genetic susceptibility to diabetes. This mechanism would be consistent with the finding that few cases of type 1 diabetes occur in subjects with celiac disease after gluten is eliminated from the diet. It is interesting that an upregulation of zonulin, a human protein analogous to the Vibrio cholerae–derived zonula occludens toxin, which is involved in tight junction regulation, has been found in the early phase of celiac disease (16–18). Genetically determined variations in factors involved in intestinal permeability, such as zonulin, could be involved in the association between celiac disease and type 1 diabetes, particularly in younger children. Well-conducted case-control studies have shown that various dietary factors are associated with risk for type 1 diabetes, such as protein intake, nitrosamines, dairy products, and cow’s milk (19–22). These unspecific observations would suggest a role for abnormal intestinal permeability, which, in genetically susceptible individuals, would activate the autoimmune reaction against ß-cells.

As recently discussed, the high prevalence of celiac disease in children with type 1 diabetes and the importance of preventing gastrointestinal malignancy and of protecting bone mineral in children and adolescents support a recommendation to screen all incident cases of type 1 diabetes for celiac disease (23). The appropriate lag time between reexaminations, however, has not been defined. Using a large cohort, we have provided evidence that, apart from patients diagnosed at onset of diabetes, 75% of children and adolescents had a diagnosis of celiac disease by 4 years’ duration of diabetes. We observed a decreasing trend of prevalence of celiac disease by duration of diabetes; in subjects with diabetes duration >9 years, the upper 95% CI limit was 1.2%, thus providing evidence that even using a conservative approach, celiac disease is rarely found after 10 years’ duration of diabetes. Therefore, our findings support the recommendation to annually screen asymptomatic children and adolescents at least by 4 years’ duration of diabetes, particularly children with age at onset of diabetes <4 years and girls. Given the cost of tests (approximately $12 per sample for EMA measurement), it is advisable to continue screening asymptomatic children to at least up to 10 years’ duration of diabetes, with intervals depending on local economic resources (23).

Another original finding of our survey was the observation of a sex difference in the prevalence of celiac disease, with an almost twofold higher risk seen in girls than in boys, independent of age or presence of other autoimmune diseases. This finding would suggest that sex-linked genetic susceptibility is involved in the etiopathogenesis of disease.

Unlike previous studies in which small clinic-based cohorts of diabetic children were studied, we extended our observations to a large cohort of diabetic children and adolescents, representative of Italian patients. Our rates are similar to those recently obtained in a long-term follow-up study based in one Italian pediatric clinic (24). Lower prevalence estimates provided by other studies are likely due to the less sensitive methods used for screening.

In conclusion, this multicenter national survey provided evidence that 1) the prevalence of biopsy-confirmed celiac disease in diabetic children and adolescents is high (6.8%); 2) the risk of celiac disease is negatively and independently associated with age at onset of diabetes, with a threefold higher risk being seen in children age <4 years than in those age >9 years; and 3) girls have a higher risk of having both diseases.

	APPENDIX

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

 
The co-authors are the members of Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology: V. Cherubini, Ancona; M. Bechaz, Aosta; A.R. Fifi, Arezzo; B. Pasquino, Bolzano; F. Gallo, Brindisi; E. Angius, M. Chessa, Cagliari-Ospedale Brotzu; M.A. Zedda, Cagliari-Clinica Pediatrica; A. La Loggia, Caltanissetta; M. Mancuso, Catania; S. Tumini, Chieti; P. Banin, Ferrara; M. Martinucci, S. Toni, Firenze; C. Mastrangelo, Foggia; M. Cotellessa, L. Minicucci, Genova; F. De Luca, F. Lombardo, Messina; R. Bonfanti, G. Chiumello, Milano; D. Iafusco, F. Prisco, Napoli; F. Cadario, Novara; C. Monciotti, Padova; G. D’Annunzio, Pavia; A. Crinò, Roma; A.M. Marinaro, A. Ogana, Sassari; I. Rabbone, Torino; V. Cauvin, Trento; G. Valerio, Udine.

	Acknowledgments

 
This study was partially supported by a grant from the MURST (Ministero dell’Università e della Ricerca Scientifica e Tecnologica), Italy.

	Footnotes

 
^* Members of the Diabetes Study Group of Italian Society of Pediatric Endocrinology and Diabetology are listed in the appendix.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

Received for publication August 13, 2003. Accepted for publication March 8, 2004.

	References

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS APPENDIX References

 

1. Collin P, Kaukinen K, Välimäki M, Salmi J: Endocrinological disorders and celiac disease. Endocr Rev 23:464–483, 2002[Abstract/Free Full Text]
   
2. Farrell R, Kelly CP: Celiac sprue. N Engl J Med 346:180–188, 2002[Free Full Text]
   
3. Perry I, Iqbal T, Cooper B: Intestinal permeability in coeliac disease (Letter). Lancet 358:1729–1730, 2001[Medline]
   
4. Ventura A, Neri E, Ughi C, Leopaldi A, Città A, Not T: Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 137:263–265, 2000[Medline]
   
5. Ventura A, Magazzù G, Greco G, for the SIGEP Study Group for Autoimmune Disorders in Celiac Disease: Autoimmune disorders in coeliac disease: relationship with duration of gluten exposure. Gastroenterology 117:303–310, 1999
   
6. Sategna Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G: Duration of gluten exposure in adult celiac disease does not correlate with the risk for autoimmune disorders. Gut 49:502–505, 2002
   
7. Biagi F, Pezzimenti D, Campanella J, Corazza GR: Gluten exposure and risk of autoimmune disorders. Gut 50:140–141, 2002
   
8. Dahlquist G, Blom L, Lönnberg G: The Swedish childhood diabetes study: a multivariate analysis of risk determinants for diabetes in different age-groups. Diabetologia 34:757–762, 1991[Medline]
   
9. Diabetes Study Group of SIEDP: Medical care for children and adolescents with diabetes. Ital J Pediatr 21:897–899, 1995
   
10. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65:909–911, 1990[Medline]
    
11. Hill ID, Bhatnagar S, Cameron DJS, De Rosa S, Maki M, Russell GJ, Troncone R: Celiac disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 35 (Suppl. 2):S78–S88, 2002
    
12. Lorini R, D’Annunzio G, Vitali L, Scaramuzza A: IDDM and autoimmune thyroid disease in the pediatric age. J Pediatr Endocrinol Metab 9:89–94, 1996
    
13. Funda DP, Kaas A, Bock T, Tlaskalova-Hagenova H, Buschard K: Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 15:323–327, 1999[Medline]
    
14. Hummel M, Bonifacio E, Naserke HE, Ziegler AG: Elimination of dietary gluten does not reduce titers of type 1 diabetes–associated autoantibodies in high-risk subjects. Diabetes Care 25:1111–1116, 2002[Abstract/Free Full Text]
    
15. Bruno G, Pinach S, Martini S, Cassader M, Pagano G, Sategna Guidetti C: Prevalence of type 1 diabetes–related autoantibodies in adults with celiac disease (Letter). Diabetes Care 26:1644–1645, 2003[Free Full Text]
    
16. Fasano A, Not T, Jang W, Uzzau S, Berti I, Tommasini A, Goldblum SE: Zonulin, a newly discovered modulator of intestinal permeability, and its expression in celiac disease (Letter). Lancet 355:1518–1519, 2000[Medline]
    
17. El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A: Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123:1607–1615, 2002[Medline]
    
18. Fasano A: Celiac disease: the past, the present, the future. Pediatrics 107:768–770, 2001[Free Full Text]
    
19. Dahlquist GG, Blom LG, Persson LA, Sadstrom AI, Wall SG: Dietary factors and the risk of developing insulin dependent diabetes in childhood. BMJ 300:1302–1306, 1990
    
20. Kostraba JN: What can epidemiology tell us about the role of infant diet in the etiology of IDDM? Diabetes Care 17:87–91, 1994[Medline]
    
21. Gerstein HC: Cow’s milk exposure and type 1 diabetes mellitus: a critical overview of the clinical literature. Diabetes Care 17:13–19, 1994[Abstract]
    
22. Virtanen SM, Räsänen L, Ylönen K, Aro A, Clayton D, Langholz B, Pitkaniemi J, Savilathi E, Lounamaa R, Toumilehto J, Åkerblom HK, Childhood in Diabetes in Finland Study Group: Early introduction of dairy products associated with increased risk of IDDM in Finnish children. Diabetes 42:1786–1790, 1993[Abstract]
    
23. Freemark M, Levitsky LL: Screening for celiac disease in children with type 1 diabetes. Diabetes Care 26:1932–1939, 2003[Free Full Text]
    
24. Barera G, Bonfanti R, Viscardi M, Bazzigalupi E, Calori G, Meschi F, Bianchi C, Chiumello G: Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 109:833–838, 2002[Abstract/Free Full Text]
    

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. LAADHAR, M. ZITOUNI, M. KALLEL-SELLAMI, R. BOUGUERRA, H. CHAABOUNI, and S. MAKNI Spectrum of Autoantibodies in Tunisian Adult Type 1 Diabetes Mellitus Ann. N.Y. Acad. Sci., June 1, 2007; 1107(1): 356 - 362. [Abstract] [Full Text] [PDF]

				D. Hansen, B. Brock-Jacobsen, E. Lund, C. Bjorn, L. P. Hansen, C. Nielsen, C. Fenger, S. T. Lillevang, and S. Husby Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease: A population-based screening study with 2 years' follow-up. Diabetes Care, November 1, 2006; 29(11): 2452 - 2456. [Abstract] [Full Text] [PDF]

				G. Goodwin, L. K. Volkening, and L. M.B. Laffel Younger Age at Onset of Type 1 Diabetes in Concordant Sibling Pairs Is Associated With Increased Risk for Autoimmune Thyroid Disease. Diabetes Care, June 1, 2006; 29(6): 1397 - 1398. [Full Text] [PDF]

				P. Narendran, E. Estella, and S. Fourlanos Immunology of type 1 diabetes QJM, August 1, 2005; 98(8): 547 - 556. [Full Text] [PDF]

				J. M. Barker, J. Yu, L. Yu, J. Wang, D. Miao, F. Bao, E. Hoffenberg, J. C. Nelson, P. A. Gottlieb, M. Rewers, et al. Autoantibody "Subspecificity" in Type 1 Diabetes: Risk for organ-specific autoimmunity clusters in distinct groups Diabetes Care, April 1, 2005; 28(4): 850 - 855. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cerutti, F. Articles by Sacchetti, C. Search for Related Content PubMed PubMed Citation Articles by Cerutti, F. Articles by Sacchetti, C. Social Bookmarking                What's this?